Globus Medical (GMED) Research & Development (2011 - 2026)

Globus Medical (GMED) has reported Research & Development for 16 consecutive years, with $36.3 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development fell 9.09% year-over-year to $36.3 million; the trailing twelve-month figure through Jun 2026 stood at $147.1 million (up 3.71% YoY), and the FY2025 full-year result was $147.2 million, down 10.08% from the prior year.
• Research & Development eased to $36.3 million in Q2 2026 per GMED's latest filing, from $36.5 million in the prior quarter.
• Across five years, Research & Development topped out at $57.3 million in Q1 2024 and bottomed at $17.4 million in Q2 2022.
• Historically, Research & Development has averaged $32.3 million across 5 years, with a median of $34.4 million in 2024.
• The sharpest annual moves came in 2022 and 2024: Research & Development sank 61.77% in 2022, then jumped 171.64% in 2024.
• Over 5 years, Research & Development stood at $19.5 million in 2022, then jumped by 167.86% to $52.3 million in 2023, then plunged by 36.06% to $33.4 million in 2024, then rose by 8.25% to $36.2 million in 2025, then gained by 0.44% to $36.3 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $36.3 million, $36.5 million, and $36.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.